The Immune Tolerance of Cancer is Mediated by IDO That is Inhibited by COX-2 Inhibitors Through Regulatory T Cells-Reference-Cited by-同舟云学术

The Immune Tolerance of Cancer is Mediated by IDO That is Inhibited by COX-2 Inhibitors Through Regulatory T Cells

Published:2009-01 Issue:1 Volume:32 Page:22-28
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Lee Sung Yong,Choi Hye Kyoung,Lee Kyoung Ju,Jung Jin Yong,Hur Gyu Young,Jung Ki Hwan,Kim Je Hyeong,Shin Chol,Shim Jae Jeong,In Kwang Ho,Kang Kyung Ho,Yoo Se Hwa

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference28 articles.

1. Human tumor antigens recognized by T lymphocytes;Boon;J Exp Med,1996

2. CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition;von Bergwelt-Baildon;Blood,2006

3. Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing glioma;Akasaki;J Immunol,2004

4. Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells;Baratelli;J Immunol,2005

5. Prostaglandin E2 impairs CD4+ T cell activation by inhibition of lck: implications in Hodgkin's lymphoma;Chemnitz;Cancer Res,2006

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NIR-II Light-Actuated Nanomotors for Enhanced Photoimmunotherapy Toward Hepatocellular Carcinoma;ACS Applied Materials & Interfaces;2024-07-19

2. Celecoxib and cisplatin dual-loaded microspheres synergistically enhance transarterial chemoembolization effect of hepatocellular carcinoma;Materials Today Bio;2024-02

3. Optimized DOX Drug Deliveries via Chitosan-Mediated Nanoparticles and Stimuli Responses in Cancer Chemotherapy: A Review;Molecules;2023-12-20

4. Effect of radiation fractionation on IDO1 via the NF-κB/COX2 axis in non-small cell lung cancer;International Immunopharmacology;2023-11

5. Interactions of IDO and the Kynurenine Pathway with Cell Transduction Systems and Metabolism at the Inflammation–Cancer Interface;Cancers;2023-05-24